Your browser doesn't support javascript.
loading
Developing Precision Invasive Neuromodulation for Psychiatry.
Bormann, Nicholas L; Trapp, Nicholas T; Narayanan, Nandakumar S; Boes, Aaron D.
Afiliación
  • Bormann NL; Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City (Bormann, Trapp); Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, Calif. (Trapp); Department of Neurology, University of Iowa Carver College of Medicine (Narayanan);
  • Trapp NT; Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City (Bormann, Trapp); Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, Calif. (Trapp); Department of Neurology, University of Iowa Carver College of Medicine (Narayanan);
  • Narayanan NS; Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City (Bormann, Trapp); Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, Calif. (Trapp); Department of Neurology, University of Iowa Carver College of Medicine (Narayanan);
  • Boes AD; Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City (Bormann, Trapp); Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, Calif. (Trapp); Department of Neurology, University of Iowa Carver College of Medicine (Narayanan);
J Neuropsychiatry Clin Neurosci ; 33(3): 201-209, 2021.
Article en En | MEDLINE | ID: mdl-33985346
ABSTRACT
Psychiatric conditions are common and often disabling. Although great strides have been made in alleviating symptoms with pharmacotherapy and psychotherapeutic approaches, many patients continue to have severe disease burden despite the best therapies available. One of the pervasive challenges to improving treatment is that present diagnostic and therapeutic strategies lag behind our modern conceptualization of the pathophysiology of these disorders. Psychiatric symptoms manifest through activity in specific neural circuits; thus, therapies capable of modulating these circuits are attractive. The investigators reviewed recent advances that facilitate treating medically refractory psychiatric disorders with intracranial neuromodulation in a way that intervenes more directly with the underlying pathophysiology. Specifically, they reviewed the prospects for using intracranial multielectrode arrays to record brain activity with high spatiotemporal resolution and identify circuit-level electrophysiological correlates of symptoms. A causal relationship of circuit electrophysiology to symptoms could then be established by modulating the circuits to disrupt the symptoms. Personalized therapeutic neuromodulation strategies can then proceed in a rational manner with stimulation protocols informed by the underlying circuit-based pathophysiology of the most bothersome symptoms. This strategy would enhance current methods in neurotherapeutics by identifying individualized anatomical targets with symptom-specific precision, circumventing many of the limitations inherent in modern psychiatric nosology and treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neurotransmisores / Medicina de Precisión / Trastornos Mentales Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: J Neuropsychiatry Clin Neurosci Asunto de la revista: NEUROLOGIA / PSIQUIATRIA Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neurotransmisores / Medicina de Precisión / Trastornos Mentales Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: J Neuropsychiatry Clin Neurosci Asunto de la revista: NEUROLOGIA / PSIQUIATRIA Año: 2021 Tipo del documento: Article